Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson

Abstract Most methods define a limited number of “target” lesions to be measured and other “non-target” lesions to be evaluated qualitatively. RECIST criteria are the most widely used although other criteria have been proposed that are derived from them based on size alone, or size and attenuation....

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic and interventional imaging 2014-07, Vol.95 (7), p.689-703
Main Authors: Fournier, L, Ammari, S, Thiam, R, Cuénod, C.-A
Format: Article
Language:English
Subjects:
Diagnostic Imaging
Hepatocellular carcinoma
Humans
MRI
Radiology
RECIST criteria
Response Evaluation Criteria in Solid Tumors
Tumour
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Most methods define a limited number of “target” lesions to be measured and other “non-target” lesions to be evaluated qualitatively. RECIST criteria are the most widely used although other criteria have been proposed that are derived from them based on size alone, or size and attenuation. Modified RECIST (mRECIST) criteria only concern hepatocellular carcinoma and only take into account the viable portion (enhanced after injection during the arterial phase). Cheson criteria are more complex as target lesions are defined differently depending on the organ (lymph nodes, liver or spleen, other organs), and involve both CT and PET scans, as well as the clinical examination and bone marrow biopsy.
ISSN:2211-5684
2211-5684
DOI:10.1016/j.diii.2014.05.002